Aktis Oncology Shares Surge Over 5% on First Trading Day
With the first biotech IPO of the year, Aktis Oncology blew past expectations, with shares jumping on the first day of trading.LATEST IPOS AND DIRECT LISTINGS:Aktis Oncologyopened on January 9 at $27. The clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large patient populations priced its upsized initial public offering of 17.65M shares of its common stock at a price to the public of $18.00 per share. The deal priced at the high-end of the $16.00-$18.00 range.Buda Juiceopened on January 8 at $12. The company priced its initial public offering of 2,666,667 shares of its common stock at the public offering price of $7.50 per share. The deal priced at the low end of its $7.50-$9.00 range. Buda Juice intends to use the net proceeds from the offering to develop and build production plants in South Carolina and Arizona/Nevada, expand capacity in its Dallas production plant, support in-store marketing and provide working capital for its expansion of its freshly crafted juices, lemonades, and wellness shots to grocery retailers.RECENT SPAC IPOS:Lafayette Digital Acquisition Iopened on January 9 at $10.01. The blank check company had priced its initial public offering of 25M units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-fourth of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the company's initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share, subject to adjustments.Bleichroeder Acquisition IIopened on Jnauary 8 at $10.03. The blank check company may pursue an acquisition opportunity in any industry, sector or geographic region. The company's primary focus, however, will be on North American and European businesses in disruptive growth sectors, which may include companies within sectors that are being transformed via technology adoption.Soren Acquisitionopened on January 7 at $10. The blank check company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution, but is focused on completing a business combination with "an attractive target business within the healthcare industry".Black Spade Acquisition IIIopened on January 6 at $9.97. The special purpose acquisition company is sponsored by an affiliate of Black Spade Capital Limited.PERFORMANCE:Prices as of 11 am ET on Monday, January 12 -Aktis Oncology – up over 5% at $23.53;Buda Juice – up almost 2% at $8.31.RECENT IPOS TO WATCH:Medlineand Andersen Groupare already seeing coverage roll out, while Starfighters Spaceis among stocks that could see new coverage this week as the quiet periods for banks that underwrote the companies' IPOs expire.UPCOMING IPOS:Upcoming IPO and direct listings expected include PicS N.V., Grayscale, Klook, Speed Group, and Lendbuzz.Clickto see upcoming IPO calendar on TipRanks.PicS N.V.filed for an initial public offering of Class A common shares, which it intends to apply to list on the Nasdaq Global Select Market under the symbol "PICS." The company said it will not seek a listing for its Class B common shares on Nasdaq or on any other exchange. The filing stated, "PicPay Netherlands, the company whose Class A common shares are being offered in this prospectus, was incorporated on December 27, 2023, as a private limited liability company under Dutch law, with its corporate seat in Amsterdam, the Netherlands, with the name 'Picpay Holdings Netherlands B.V.' Prior to the closing of this offering, the issuer will be converted into a public limited liability company under Dutch law with the name 'PicS N.V.'... At PicPay, we believe financial services should be mobile, frictionless, and instantaneous. Our mission is to empower consumers and businesses across Brazil with innovative solutions to redefine the way people manage their traditional daily finances. We break down the barriers to traditional financial services and are driven by a vision of a future where financial services are accessible for all. We are committed to simplifying financial transactions, fostering economic inclusion and providing the tools and resources for people to achieve their financial goals."GrayscaleInvestments filed a prospectus for an initial public offering on the New York Stock Exchange under the ticker symbol "GRAY." Grayscale says it is the largest digital asset-focused investment platform in the world, with $35B in assets under management as of September 30. "Our mission is to make digital asset investing simple and open to every investor. Founded in 2013, we have pioneered regulated access to the digital asset class. Our platform spans the full spectrum of institutional-grade solutions, providing investors with the broadest and most diverse suite of digital asset-focused investment products in the United States based on number of products," the company added.Klook Technology, which identifies itself as "the largest pan-regional experiences platform in Asia-Pacific" by gross transaction volume in 2024, announced that it has filed a registration statement on Form F-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of American Depositary Shares representing its ordinary shares. The company has applied to list the ADSs on the New York Stock Exchange under the ticker symbol "KLK". The number of ADSs to be offered and the price range for the proposed offering have not yet been determined.Speed Groupfiled a prospectus for 2.5M share initial public offering. It expects the IPO price to be in the range of $4.00 to $5.00 per. The company's operating subsidiary, Speed Logistics, is an e-commerce logistics provider providing end-to-end logistics solution in Hong Kong, Europe and North America. The services include warehousing, customs clearance, air transportation, and final delivery from the European airports. For the years ended June 30, 2024 and 2025, Speed's revenues were $17.9M and $22.64M, respectively.Lendbuzz Inc.is offering an undetermined number of shares of its common stock and the selling stockholders identified in this prospectus are offering additional shares of common stock, according to an initial public offering prospectus filed with the SEC. The company has applied to list its common stock on the Nasdaq Global Select Market under the symbol "LBZZ." The prospectus states: "Our mission is to offer fair access to credit for underserved populations. We are a financial technology company that utilizes artificial intelligence, or AI, and machine learning algorithms to better assess consumer credit risk and expand access to credit. We seamlessly process large sets of data through advanced computational approaches to more accurately predict a consumer's creditworthiness. Our business benefits both consumers through expanded access to credit, and auto dealerships via increased vehicle sales."OTHER IPO NEWS:Construction equipment rental firm EquipmentShare.com, which filed publicly for a listing on December 9, may begin formal marketing for its initial public offering as soon as next week and could raise about $1B, a person familiar with the matter told Bloomberg's Bailey Lipschultz and Anthony Hughes. Motive Technologies, which makes artificial intelligence-enabled fleet management software and filed its IPO paperwork publicly on December 23, may also begin formal marketing next week as it seeks to raise around $600M, the report noted that a person with knowledge of the deal said."Opening Day" is The Fly's recurring series of stories on the latest initial public offerings, their performance, and upcoming IPOs.
Trade with 70% Backtested Accuracy
Analyst Views on MDLN
About MDLN
About the author

- Earnings Overview: Medline Inc reported a quarterly loss of $0.01 per share, missing the analyst consensus estimate of $0.18 per share, indicating pressure on profitability.
- Sales Performance: The company achieved quarterly sales of $7.787 billion, exceeding the analyst consensus estimate of $7.547 billion, demonstrating strong market demand and reinforcing its position in the healthcare sector.
- Customer Signing Update: CEO Jim Boyle noted that total new customer signings reached $2.4 billion for 2025, reflecting customer confidence in Medline's value, service, and reliability, enhancing the company's capability to support health systems.
- Stock Price Reaction: Following the earnings announcement, Medline's shares rose by 3.4% to $49.80, indicating market optimism regarding the company's future prospects.
- Earnings Report: Medline Inc.'s Q4 results reveal a GAAP EPS of -$0.01, missing expectations by $0.14, while revenue reached $7.8 billion, up 14.8% year-over-year, exceeding forecasts by $290 million, indicating robust market performance.
- Growth Drivers: The revenue increase was primarily driven by strong growth in both the Medline Brand and Supply Chain Solutions segments, highlighting sustained demand in the medical supply sector and enhancing the company's competitive position.
- Future Outlook: The company anticipates organic sales growth of 8% to 9% for 2026, with adjusted EBITDA projected between $3.5 billion and $3.6 billion, reflecting management's confidence in future performance and ongoing growth potential.
- Successful IPO: Medline Inc. successfully raised $6.26 billion in its IPO at a price of $29 per share, with the stock surging 28%, demonstrating strong market confidence in its business model and growth prospects.

- Stock Market Movement: Stock futures were rising on Wednesday, indicating positive investor sentiment.
- Response to Political Events: Investors appeared to overlook President Donald Trump’s State of the Union address, focusing instead on market trends.
- Strong IPO Performance: Medline Inc. successfully raised $6.26 billion in its IPO by pricing shares at $29 each, reflecting strong market confidence in its business model and providing ample funding for future expansion.
- High Market Demand: The IPO attracted significant investor interest, with shares surging 28% upon opening, indicating strong recognition of Medline's growth potential and profitability in the medical supply sector, which may further enhance its market share.
- Earnings Forecast: Medline is set to announce its Q4 earnings on February 25, with consensus estimates predicting an EPS of $0.24 and revenue of $7.51 billion, providing crucial insights into the company's financial health for investors.
- Strengthened Industry Position: Medline boasts a solid physical moat in the medical supply industry, and with visible earnings growth, the company is poised for sustained market expansion and revenue growth in the coming years.
- Evercore Strong Performance: Evercore's recent quarterly earnings report showed strong top and bottom line beats, with analyst Ebrahim Poonawala noting that the firm's exposure to large-cap M&A and growth in non-M&A advisory revenues will support EPS growth, making it a compelling investment opportunity.
- Live Nation Growth Potential: Live Nation is viewed as a leader in global live entertainment, with analyst Peter Henderson highlighting robust demand and healthy consumer spending trends that will underpin its medium to long-term growth; despite regulatory pressures, the stock remains attractive, having risen 16% in the past month.
- Medline Market Leader: Analyst Andrew Obin initiated coverage of Medline with a buy rating, forecasting sustainable high-single digit organic growth driven by market share gains in the $175 billion U.S. market, with the stock up 13% over the past month.
- Waystar Steady Growth: Waystar is well-positioned for steady growth supported by stable end-market demand for revenue cycle management solutions, with analysts believing the company can expand relationships with 18 of the top 22 hospitals, driving further growth opportunities.
- Executive Attendance: Medline's CEO Jim Boyle and CFO Mike Drazin are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach on March 11, 2026, showcasing the company's leadership in the healthcare sector.
- Webcast Arrangement: The presentation will be available via a live webcast on Medline's Investor Relations website, allowing global investors to stay updated on the company's latest developments in real-time.
- Replay Availability: Following the presentation, the webcast will be accessible on Medline's Investor Relations website for six months, ensuring that investors who miss the live event can still obtain relevant information, thereby enhancing transparency.
- Company Background: Medline is the largest provider of medical-surgical products and supply chain solutions, employing over 43,000 people and operating in more than 100 countries, dedicated to improving clinical, financial, and operational outcomes for healthcare providers.






